Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3762036015 | Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3762037012 | Loteprednol etabonate 2 mg/mL eye suspension | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 4583231000052119 | loteprednoletabonat 2 milligram/milliliter, suspension för oftalmiskt bruk | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) | Is a | Product containing loteprednol (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) | Is a | loteprednoletabonat för oftalmiskt bruk | false | Inferred relationship | Some | ||
| Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has active ingredient | Loteprednol etabonate (substance) | false | Inferred relationship | Some | ||
| Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has active ingredient | Corticosterone | false | Inferred relationship | Some | ||
| Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has active ingredient | binjurehormonmedel | false | Inferred relationship | Some | ||
| Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has active ingredient | Glucocorticoid hormone | false | Inferred relationship | Some | ||
| Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has manufactured dose form | Ocular dose form (dose form) | false | Inferred relationship | Some | ||
| Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has manufactured dose form | Eye suspension | true | Inferred relationship | Some | ||
| Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) | Is a | Product manufactured as ocular dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some | ||
| Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
| Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has precise active ingredient | Loteprednol etabonate (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has basis of strength substance (attribute) | Loteprednol etabonate (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) | räkning av bas i aktiv ingrediens | ett | false | Inferred relationship | Some | ||
| Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) | har täljarvärde för koncentrationsstyrka | två | false | Inferred relationship | Some | 1 | |
| Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) | har nämnarvärde som visar koncentrationsstyrka | ett | false | Inferred relationship | Some | 1 | |
| Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) | Is a | Product containing only loteprednol in ocular dose form (medicinal product form) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR